Discontinuation report PMS-ALENDRONATE-FC
| Report ID | 129698 |
| Drug Identification Number | 02284006 |
| Brand name | PMS-ALENDRONATE-FC |
| Common or Proper name | ALENDRONATE |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ALENDRONIC ACID |
| Strength(s) | 70MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-12-07 |
| Remaining supply date | 2020-12-07 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Demand transferred to 0 5760601684 3 pms-ALENDRONATE FC 70mg TABS BLI 1X4 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-12-08 | English | Compare |
| v6 | 2020-12-07 | French | Compare |
| v5 | 2020-12-07 | English | Compare |
| v4 | 2020-12-07 | French | Compare |
| v3 | 2020-12-07 | English | Compare |
| v2 | 2020-12-07 | French | Compare |
| v1 | 2020-12-07 | English | Compare |
Showing 1 to 7 of 7